Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: The present disclosure relates to methods of slowing cognitive decline in mild-to-moderate and moderate Alzheimer's disease, and other Tau pathologies, using anti-Tau antibodies. The disclosure provides first-in-class immunotherapy for use in reducing clinical decline in mild-to-moderate AD and moderate AD, in particular, significantly reducing rate of decline in cognitive capacity to a clinically meaningful extent, and significantly retaining memory. The disclosure also relates to use of anti-Tau antibodies to intercept cell-to-cell spread of pathological Tau in the brains of patients with AD or related Tauopathies.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: A computer implemented method of performing single pass optical character recognition (OCR) including at least one fully convolutional neural network (FCN) engine including at least one processor and at least one memory, the at least one memory including instructions that, when executed by the at least processor, cause the FCN engine to perform a plurality of steps. The steps include preprocessing an input image, extracting image features from the input image, determining at least one optical character recognition feature, building word boxes using the at least one optical character recognition feature, determining each character within each word box based on character predictions and transmitting for display each word box including its predicted corresponding characters.

Abstract: A computer implemented method of performing single pass optical character recognition (OCR) including at least one fully convolutional neural network (FCN) engine including at least one processor and at least one memory, the at least one memory including instructions that, when executed by the at least processor, cause the FCN engine to perform a plurality of steps. The steps include preprocessing an input image, extracting image features from the input image, determining at least one optical character recognition feature, building word boxes using the at least one optical character recognition feature, determining each character within each word box based on character predictions and transmitting for display each word box including its predicted corresponding characters.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: A computer implemented method of performing single pass optical character recognition (OCR) including at least one fully convolutional neural network (FCN) engine including at least one processor and at least one memory, the at least one memory including instructions that, when executed by the at least processor, cause the FCN engine to perform a plurality of steps. The steps include preprocessing an input image, extracting image features from the input image, determining at least one optical character recognition feature, building word boxes using the at least one optical character recognition feature, determining each character within each word box based on character predictions and transmitting for display each word box including its predicted corresponding characters.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological solution; wherein the biocompatible polymer is soluble in the non-physiological solution and insoluble in a physiological solution. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: Polymeric compositions are described comprising a biocompatible polymer including a biodegradable linkage to a visualization agent and a non-physiological pH solution; wherein the biocompatible polymer is soluble in the non-physiological pH solution and insoluble at a physiological pH. Methods of forming the solutions and polymers are disclosed as well as methods of therapeutic use.

Abstract: Described are devices for implantation comprising a hydrogel filament wherein the hydrogel filament includes a low molecular weight ethylenically unsaturated macromer, an ethylenically unsaturated monomer, and a visualization agent. Methods of making and using these devices are also described.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.

Abstract: Described herein are apparatus, compositions, systems and methods for occluding vascular structures and vascular malformations with radiopaque hydrogel filaments. The filaments can contain no support members and can be CT and MR compatible. Methods of forming such filaments are also disclosed.

Abstract: Polymer particle embolics and methods of making same are described. The particle embolics can be used as embolization agents.